Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bioxyne Limited ( (AU:BXN) ) has shared an update.
Bioxyne Limited has announced the issuance of 115,600,000 shares at $0.025 per share as part of a capital raise, in accordance with the Corporations Act. This move, approved by the Board, complies with relevant legal provisions and signifies a strategic effort to bolster the company’s financial standing.
More about Bioxyne Limited
YTD Price Performance: -10.0%
Average Trading Volume: 3,483,006
Technical Sentiment Signal: Sell
Current Market Cap: A$55.33M
For a thorough assessment of BXN stock, go to TipRanks’ Stock Analysis page.